Increasing Incidence of Melanoma Among Young Adults

Published Online: Monday, January 28, 2013
Follow Pharmacy_Times:
In this video, Kurtis Reed, MD, lead author of a study published in the April 2012 edition of Mayo Clinic Proceedings on the incidence of melanoma among young adults, discusses its findings. The study found that, since the 1970s, the incidence of melanoma has increased 6-fold among all young adults and more than 8-fold among young women. Dr. Reed notes that these results indicate that melanoma is not just a disease of elderly patients and that health care providers should ensure that young adults receive appropriate screening for the condition and education about risk factors, prevention, and detection.

Related Articles
Teikoku Pharma USA has submitted a New Drug Application to the FDA for the product.
Cancer drug prices have increased 10% each year since 1995, even after adjusting for inflation and incremental health benefits.
Cyramza, manufactured by Eli Lilly and Company, is an angiogenesis inhibitor indicated for the treatment of patients with advanced or metastatic gastric cancer or gastroesophageal junction adenocarcinoma with disease progression on or after treatment with prior fluoropyrimidine- or platinum-containing chemotherapy.
FDA laboratory analysis has confirmed that 3 products promoted as weight-loss supplements contain hidden drug ingredients with known risks.
Latest Issues
  • photo
    Pharmacy Times
    photo
    Health-System Edition
    photo
    Directions in Pharmacy
    photo
    OTC Guide
    photo
    Generic Supplements
  • photo
    Pharmacy Careers
    photo
    Specialty Pharmacy Times
    photo
    Generic
$auto_registration$